4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001628280-23-008357
Options or other derivatives
- Chief Scientific Officer acquired 167,088 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Smeal Tod Chief Scientific Officer | 2023-03-15 | Grant or award · Stock Options | +167,088 | 442,176 | D | ||
Loading xslF345X03/wf-form4_167900293568224.xml…